Home > Name List By 4 > 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

CAS No 169590-42-5 , 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

  • Name: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
  • Synonyms: Celecoxi; Onsenal;Celebrex; Celocoxib; Celebra;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; SC 58635; Xilebao; Celecox; 169590-42-5;
  • CAS Registry Number:
  • Transport: UN 2811
  • Melting Point: 157-159 ºC
  • Boiling Point:
  • Density: 1.43 g/cm3
  • Water Solubility: Insoluble
  • Safety Statements: S22;S24/25;S28;S37/39;
  • Hazard Symbols: UN NO.
  • Molecular Weight: 381.37217
  • InchiKey: RZEKVGVHFLEQIL-UHFFFAOYSA-N
  • InChI: InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,
    19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
  • Risk Statements: R20/21/22
  • Molecular Formula: C17H14F3N3O2S
  • Molecular Structure:CAS No:169590-42-5 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
Search by region :

Select to

169590-42-5 CELECOXIB CELEBREX; CELEBRA; CELOCOXIB; CELECOX; ONSENAL; SOLEXA; SC-58635; YM-177; 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE

  • United States LC Laboratories [Manufacturer]
  • Tel: 781-937-0777
  • Fax: 781-938-5420
  • Address: LC Laboratories
    165 New Boston Street
    Woburn, MA 01801 USA null,nullUnited States
Contact Supplier

169590-42-5 Celecoxib

Contact Supplier

169590-42-5 Celecoxib

Contact Supplier

169590-42-5 Celecoxib

Contact Supplier

169590-42-5; 184007-95-2 Celecoxib

  • China Fine Chemicals Group Co.,Ltd. null
  • Tel: +86-576-84285761
  • Fax: +86-576-84276736 84276530
  • Address: 5 Rouji Rd. Huangyan, Zhejiang, China Huangyan,ZhejiangChina
Contact Supplier

169590-42-5 CELECOXIB

  • United States CPL, Inc. [Manufacturer]
  • Tel: 301-208-0069
  • Fax: 301-208-6784
  • Address: CPL, Inc.
    9801 Washingtonian Boulevard
    Suite 220
    Gaithersburg, MD 20878
    USA null,nullUnited States
Contact Supplier

169590-42-5 Celecoxib

  • China NANTONG CHEM-TECH.(GROUP) CO.,LTD [Manufacturers]
  • Tel: 0086-513-85081108 85335860
  • Fax: 0086-513-85085921
  • Address: 7/F Beihao BLDG, No. 91,Zhongxiu Middle Road, Nantong,China Nantong,jiangsuChina
Contact Supplier

169590-42-5; 184007-95-2 Celecoxib

Contact Supplier

169590-42-5; 184007-95-2 Celecoxib

  • India Aastrid International null
  • Tel: +91-22-26858570
  • Fax: +91-22-26859570
  • Address: 247-248, Udyog Bhavan, Sonawala Lane, Goregaon (East),Mumbai: 400 063, INDIA. null,nullIndia
Contact Supplier

169590-42-5 Celecoxib

  • China Shanghai Sunheat Chemicals Co.,Ltd. [Manufacturers]
  • Tel: +86-21-66083127
  • Fax: +86-21-66080360
  • Address: Rm403,Building 16,Lane 1051,Zhennan Rd,Shanghai,China Shanghai,ShanghaiChina
Contact Supplier

Select to

References of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
Title: Celecoxib
CAS Registry Number: 169590-42-5
CAS Name: 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
Manufacturers' Codes: SC-58635; YM-177
Trademarks: Celebrex (Pfizer); Onsenal (Pfizer)
Molecular Formula: C17H14F3N3O2S
Molecular Weight: 381.37
Percent Composition: C 53.54%, H 3.70%, F 14.94%, N 11.02%, O 8.39%, S 8.41%
Literature References: Selective cyclooxygenase-2 (COX-2) inhibitor. Prepn: J. J. Talley et al., WO 9515316; eidem, US 5466823 (both 1995 to Searle); T. D. Penning et al., J. Med. Chem. 40, 1347 (1997). Clinical pharmacology: P. E. Lipsky, P. C. Isakson, J. Rheumatol. 24, Suppl. 49, 9 (1997). Clinical trials in arthritis: L. S. Simon et al., Arthritis Rheum. 41, 1591 (1998). Evaluation of risk of gastrointestinal toxicity in patients with arthritis: F. E. Silverstein et al., J. Am. Med. Assoc. 284, 1247 (2000). Clinical trial in familial adenomatous polyposis: G. Steinbach et al., N. Engl. J. Med. 342, 1946 (2000).
Properties: Pale yellow solid, mp 157-159°.
Melting point: mp 157-159°
Therap-Cat: Anti-inflammatory. In treatment of familial adenomatous polyposis.
Keywords: Anti-inflammatory (Nonsteroidal); Cyclooxygenase-2 Selective Inhibitor.